Related Experiment Video
Updated: Jul 7, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Prostate cancer prevention by nutritional means to alleviate metabolic syndrome
1Department of Physiological Science, University of California, Los Angeles, CA 90096-1606, USA. jbarnard@physci.ucla.edu
Abstract:
In 1987 when Reaven introduced syndrome X (metabolic syndrome, or MS), we were studying skeletal muscle insulin resistance and found that when rodents were fed a high-fat, refined-sugar (HFS) diet, insulin resistance developed along with aspects of MS, including hyperinsulinemia, hypertension, hypertriglyceridemia, and obesity. MS was controlled in rodents by switching them to a low-fat, starch diet and was controlled in humans with a low-fat starch diet and daily exercise (Pritikin Program). Others reported inverse relations between serum insulin and sex hormone-binding globulin (SHBG). When subjects were placed on the Pritikin Program, insulin fell and SHBG rose and it was suggested that prostate cancer might also be an aspect of MS. A bioassay was developed with tumor cell lines grown in culture and stimulated with serum before and after a diet and exercise intervention. Diet and exercise altered serum factors that slowed the growth rate and induced apoptosis in androgen-dependent prostate cancer cells. Changes in serum with diet and exercise that might be important include reductions in insulin, estradiol, insulin-like growth factor-I (IGF-I), and free testosterone with increases in SHBG and IGF binding protein-1. Hyperinsulinemia stimulates liver production of IGF-I, plays a role in the promotion of prostate cancer, and thus is the cornerstone for both MS and prostate cancer. Adopting a low-fat starch diet with daily exercise controls MS and should reduce the risk of prostate cancer.
Insights
Metabolic syndrome (MS) and prostate cancer share common roots in hyperinsulinemia. A low-fat, starch diet and daily exercise effectively manage MS and may reduce prostate cancer risk by altering key serum factors.
Area of Science:
- Endocrinology
- Metabolic Syndrome Research
- Oncology
Background:
- Metabolic syndrome (MS), initially termed syndrome X, is characterized by insulin resistance, hyperinsulinemia, hypertension, hypertriglyceridemia, and obesity.
- Studies indicate a link between MS and prostate cancer, with hyperinsulinemia potentially promoting tumor growth.
- Inverse relationships between serum insulin and sex hormone-binding globulin (SHBG) have been observed.
Purpose of the Study:
- To investigate the impact of diet and exercise on metabolic syndrome and prostate cancer.
- To explore the role of serum factors in the development and progression of prostate cancer.
- To determine if lifestyle interventions can influence factors related to both MS and prostate cancer.
Main Methods:
- Rodent models were fed high-fat, refined-sugar (HFS) diets to induce MS, then switched to low-fat, starch diets.
- Human subjects underwent a low-fat starch diet and daily exercise program (Pritikin Program).
- A bioassay using cultured prostate cancer cell lines stimulated with pre- and post-intervention serum was employed.
Main Results:
- A low-fat starch diet controlled MS in rodents and humans.
- Diet and exercise interventions altered serum factors, reducing growth and inducing apoptosis in prostate cancer cells.
- Key serum changes included decreased insulin, estradiol, IGF-I, and free testosterone, with increased SHBG and IGF binding protein-1.
Conclusions:
- Hyperinsulinemia is a central factor in both MS and prostate cancer.
- A low-fat starch diet combined with daily exercise can manage MS.
- This lifestyle intervention shows potential for reducing prostate cancer risk by modulating critical serum biomarkers.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Atherosclerosis III: Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Coronary Artery Disease IV: Preventive Measures
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
